English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45422/58598 (78%)
造訪人次 : 2534303      線上人數 : 199
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/6885


    題名: 無機砷代謝酵素之基因多形性與頸動脈粥狀硬化之相關性研究
    Association between genetic polymorphisms of arsenic metabolic enzymes and carotid atherosclerosis
    作者: 謝佩帆
    Pei-Fan, Hsieh
    貢獻者: 公共衛生學研究所
    關鍵詞: 
    頸動脈粥狀硬化
    嘌呤核苷
    磷酸化酶
    榖胱苷

    硫轉移酶
    omega
    三價砷甲基化轉移酶
    日期: 2009
    上傳時間: 2009-09-16 15:28:27 (UTC+8)
    摘要: 動脈粥狀硬化的病理過程是由炎性損傷誘發平滑肌細胞的增生,導致晚期血栓形成與血管的纖維性阻塞。人體暴露於無機砷之後,在無機砷代謝的過程中,體內氧化壓力會隨之增加,進而誘發發炎反應。然而,無機砷代謝酵素的基因多形性會導致個體對於無機砷代謝情形的差異,進而造成對於頸動脈粥狀硬化易感性的不同。因此,本研究主要目的為探討砷暴露與無機砷代謝酵素嘌呤核苷磷酸化酶(PNP)、榖胱苷肽硫轉移酶omega(GSTO1,GSTO2)、三價砷甲基化轉移酶(As3MT)的基因多形性對於罹患頸動脈粥狀硬化的獨立及交互作用關係。
    本研究對象為863位40歲以上參與民國86年於蘭陽盆地舉行之健康檢查的民眾,依照醫師判定為頸動脈粥狀硬化者共384人為個案組,對照組為479人。利用結構式問卷以標準化流程收集研究對象之基本人口學特性並測量其血清生化值。使用聚合酶連鎖反應-限制片段長度基因多形性(Polymerase chain reaction- Restriction fragment length polymorphism, PCR-RFLP)進行基因型的判定。砷暴露及基因多形性對於頸動脈粥狀硬化的獨立及交互作用以邏輯式回歸分析估計。
    結果顯示 PNP Gly51Ser與 Pro57Pro 上帶有危險基因型者會增加罹患頸動脈粥狀硬化的風險(OR=1.3與1.6), PNP 危險單套型者具有1.5倍的罹病風險,危險雙套型者則具有1.6倍的罹病風險。進一步進行交互作用分析,當飲水砷濃度大於50ppb且攜帶危險單套型者,罹病風險是飲水砷濃度小於等於50ppb且不具有危險單套型者的2.3倍。當累積砷暴露量大於1.66mg/L*year者且攜帶危險單套型者,罹病風險是累積砷暴露量小於等於1.66mg/L*year且不具有危險單套型者的2.3倍。隨著飲水砷濃度或累積砷暴露量且攜帶危險單套型的增加,罹病風險也會隨之提高,達統計顯著意義(P<0.0003)。以上的相關性在不具有糖尿病與高血壓的族群中與罹病關係更為顯著。

    Atherogenesis is a pathophysiological process, which is characterized with the progression from inflammation and smooth muscle cell proliferation to late stage of thrombotic and fibrotic obliterations of the vessels. Level of oxidative stress would increase in human body after long-term exposure to arsenic through drinking well water. However, individual susceptibility to arsenic-induced carotid atherosclerosis were different due to various capability of arsenic metabolism. The aim of this study was to identify the relationship between carotid atherosclerosis and genetic polymorphisms of arsenic related metabolic genes including purine nucleoside phosphorylase(PNP), glutathione S-transferase omega(GSTO1, GSTO2), arsenite methyltransferase (As3MT).
    A total of 863 residents aged equal and greater than 40 years and lived in Lanyan Basin were recruited in this study. Among them, 384 subjects were identified as cases based on physician’s diagnosis. All subjects were interviewed by well-trained research assistants to collect questionnaire data including demographic characteristics and serum biochemistry indices. Genetic polymorphisms of PNP, GSTO1, GSTO2 and As3MT were detected by PCR-RFLP. Logistic regression model was used to estimate odds ratio (OR)and 95% confidence interval(CI)of various risk factors of carotid atherosclerosis.
    Our results showed that subjects with the T allele of PNP Gly51Ser or Pro57Pro had significantly increased risk of carotid atherosclerosis(OR=1.3 and 1.6). A significantly increased risk of carotid atherosclerosis was also found in subjects with the risk haplotypes and diplotypes of PNP(OR=1.5 and 1.6). Those who with risk PNP haplotypes and either had ingested well water contained arsenic level> 50μg/L or had cumulative arsenic exposure>1.66 mg/L*year would have elevated 2.3-fold risk of carotid atherosclerosis. Dose-response relationships between increased risk haplotypes of PNP and risk of carotid atherosclerosis were observed among subjects with either drank well water contained arsenic level>50μg/L or with cumulative arsenic exposure>1.66 mg/L*year. A highest risk of carotid atherosclerosis was also found in subjects without hypertension and diabetes mellitus.
    In conclusion, this study provide the strong evidence that genetic polymorphisms of PNP gene was associated with carotid atherosclerosis. Prominent risk of carotid atherosclerosis were also found among study subjects with risk haplotypes of PNP, high exposure to arsenic and without hypertension and diabetes mellitus.
    資料類型: thesis
    顯示於類別:[公共衛生學系暨研究所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    摘要.doc30KbMicrosoft Word152檢視/開啟
    摘要.pdf127KbAdobe PDF275檢視/開啟
    摘要.ppt112KbMicrosoft Powerpoint235檢視/開啟
    摘要.ps409KbPostscript102檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋